BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15741801)

  • 1. Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study.
    Libourel EJ; Bank I; Veeger NJ; Hamulyàk K; Middeldorp S; Prins MH; Büller HR; van der Meer J
    Blood Coagul Fibrinolysis; 2005 Mar; 16(2):135-40. PubMed ID: 15741801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in absolute risk of venous and arterial thrombosis between familial protein S deficiency type I and type III. Results from a family cohort study to assess the clinical impact of a laboratory test-based classification.
    Brouwer JL; Veeger NJ; van der Schaaf W; Kluin-Nelemans HC; van der Meer J
    Br J Haematol; 2005 Mar; 128(5):703-10. PubMed ID: 15725093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.
    Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):713-20. PubMed ID: 11734673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes.
    Brouwer JL; Veeger NJ; Kluin-Nelemans HC; van der Meer J
    Ann Intern Med; 2006 Dec; 145(11):807-15. PubMed ID: 17146065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
    Folkeringa N; Coppens M; Veeger NJ; Bom VJ; Middeldorp S; Hamulyak K; Prins MH; Büller HR; van der Meer J
    Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
    Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects.
    Folkeringa N; Brouwer JL; Korteweg FJ; Veeger NJ; Erwich JJ; van der Meer J
    Br J Haematol; 2007 Jul; 138(1):110-6. PubMed ID: 17555454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.
    Martinelli I; Mannucci PM; De Stefano V; Taioli E; Rossi V; Crosti F; Paciaroni K; Leone G; Faioni EM
    Blood; 1998 Oct; 92(7):2353-8. PubMed ID: 9746774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiency.
    Castaman G; Tosetto A; Cappellari A; Ruggeri M; Rodeghiero F
    Blood Coagul Fibrinolysis; 2000 Jun; 11(4):321-6. PubMed ID: 10847418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
    Martinelli I; Bucciarelli P; Margaglione M; De Stefano V; Castaman G; Mannucci PM
    Br J Haematol; 2000 Dec; 111(4):1223-9. PubMed ID: 11167765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal loss in women with hereditary thrombophilic defects and concomitance of other thrombophilic defects: a retrospective family study.
    Korteweg FJ; Folkeringa N; Brouwer JL; Erwich JJ; Holm JP; van der Meer J; Veeger NJ
    BJOG; 2012 Mar; 119(4):422-30. PubMed ID: 22324918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of venous thromboembolism in thai patients.
    Angchaisuksiri P; Atichartakarn V; Aryurachai K; Archararit N; Rachakom B; Atamasirikul K; Tiraganjana A
    Int J Hematol; 2007 Dec; 86(5):397-402. PubMed ID: 18192106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders.
    Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Br J Haematol; 2002 Mar; 116(3):625-31. PubMed ID: 11849222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
    Bank I; Libourel EJ; Middeldorp S; Van Pampus EC; Koopman MM; Hamulyák K; Prins MH; Van Der Meer J; Büller HR
    Arch Intern Med; 2004 Sep; 164(17):1932-7. PubMed ID: 15451770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease.
    De Stefano V; Zappacosta B; Persichilli S; Rossi E; Casorelli I; Paciaroni K; Chiusolo P; Leone AM; Giardina B; Leone G
    Br J Haematol; 1999 Aug; 106(2):564-8. PubMed ID: 10460623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.